Supplementary Table S1 from A Phase II Study of Docetaxel and Pembrolizumab plus Interleukin 12 Gene Therapy in Nonmetastatic, Anthracycline-Refractory Triple-Negative Breast Cancer (INTEGRAL)
Authors:
- Polly NiravathPNPolly Niravath
- Ann C. AnselmeAAAnn C. Anselme
- Ivonne UzairIUIvonne Uzair
- Kai SunKSKai Sun
- Hanh MaiHMHanh Mai
- Jian GuanJGJian Guan
- Mailin LiMLMailin Li
- Jenying DengJDJenying Deng
- Wei QianWQWei Qian
- Jianying ZhouJZJianying Zhou
- Liliana GuzmanLGLiliana Guzman
- Kelsey BanagloriosoKBKelsey Banaglorioso
Open Access
- 1 October 2026
- other
- Published by American Association for Cancer Research (AACR)